Cargando…

I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis

OBJECTIVE: Little is known about the experiences, values, and needs of people without arthritis who undergo predictive biomarker testing for the development of rheumatoid arthritis (RA). Our study aimed to explore the perspectives of these individuals and describe their information needs. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosor, Erika, Stoffer‐Marx, Michaela, Steiner, Günter, Raza, Karim, Stack, Rebecca J., Simons, Gwenda, Falahee, Marie, Skingle, Diana, Dobrin, Mircia, Schett, Georg, Englbrecht, Matthias, Smolen, Josef S., Kjeken, Ingvild, Hueber, Axel J., Stamm, Tanja A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064954/
https://www.ncbi.nlm.nih.gov/pubmed/30710453
http://dx.doi.org/10.1002/acr.23841
_version_ 1783504967511834624
author Mosor, Erika
Stoffer‐Marx, Michaela
Steiner, Günter
Raza, Karim
Stack, Rebecca J.
Simons, Gwenda
Falahee, Marie
Skingle, Diana
Dobrin, Mircia
Schett, Georg
Englbrecht, Matthias
Smolen, Josef S.
Kjeken, Ingvild
Hueber, Axel J.
Stamm, Tanja A.
author_facet Mosor, Erika
Stoffer‐Marx, Michaela
Steiner, Günter
Raza, Karim
Stack, Rebecca J.
Simons, Gwenda
Falahee, Marie
Skingle, Diana
Dobrin, Mircia
Schett, Georg
Englbrecht, Matthias
Smolen, Josef S.
Kjeken, Ingvild
Hueber, Axel J.
Stamm, Tanja A.
author_sort Mosor, Erika
collection PubMed
description OBJECTIVE: Little is known about the experiences, values, and needs of people without arthritis who undergo predictive biomarker testing for the development of rheumatoid arthritis (RA). Our study aimed to explore the perspectives of these individuals and describe their information needs. METHODS: A qualitative, multicenter interview study with a thematic analysis was conducted in Austria, Germany and the UK. Individuals were interviewed who underwent predictive biomarker testing for RA and had a positive test result but no diagnosis of any inflammatory joint disease. Participants included patients with arthralgia and asymptomatic individuals. Information and education needs were developed from the qualitative codes and themes using the Arthritis Educational Needs Assessment Tool as a frame of reference. RESULTS: Thematic saturation was reached in 34 individuals (76% female, 24 [71%] with arthralgia, and 10 [29%] asymptomatic individuals). Thirty‐seven codes were summarized into 4 themes: 1) decision‐making around whether to undergo initial predictive testing, 2) willingness to consider further predictive tests, and/or 3) preventive interventions, including medication, and 4) varying reactions after receiving a positive test result. Individuals with arthralgia were more likely to be willing to take preventive action, undergo further testing, and experience psychological distress than asymptomatic individuals. All participants expressed the need for tailored, patient‐understandable information. CONCLUSION: Individuals at risk of RA are currently the subjects of research aimed at developing better predictive strategies and preventive approaches. Their perceptions and needs should be addressed to inform the future development of interventions combined with education.
format Online
Article
Text
id pubmed-7064954
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70649542020-03-16 I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis Mosor, Erika Stoffer‐Marx, Michaela Steiner, Günter Raza, Karim Stack, Rebecca J. Simons, Gwenda Falahee, Marie Skingle, Diana Dobrin, Mircia Schett, Georg Englbrecht, Matthias Smolen, Josef S. Kjeken, Ingvild Hueber, Axel J. Stamm, Tanja A. Arthritis Care Res (Hoboken) Rheumatoid Arthritis OBJECTIVE: Little is known about the experiences, values, and needs of people without arthritis who undergo predictive biomarker testing for the development of rheumatoid arthritis (RA). Our study aimed to explore the perspectives of these individuals and describe their information needs. METHODS: A qualitative, multicenter interview study with a thematic analysis was conducted in Austria, Germany and the UK. Individuals were interviewed who underwent predictive biomarker testing for RA and had a positive test result but no diagnosis of any inflammatory joint disease. Participants included patients with arthralgia and asymptomatic individuals. Information and education needs were developed from the qualitative codes and themes using the Arthritis Educational Needs Assessment Tool as a frame of reference. RESULTS: Thematic saturation was reached in 34 individuals (76% female, 24 [71%] with arthralgia, and 10 [29%] asymptomatic individuals). Thirty‐seven codes were summarized into 4 themes: 1) decision‐making around whether to undergo initial predictive testing, 2) willingness to consider further predictive tests, and/or 3) preventive interventions, including medication, and 4) varying reactions after receiving a positive test result. Individuals with arthralgia were more likely to be willing to take preventive action, undergo further testing, and experience psychological distress than asymptomatic individuals. All participants expressed the need for tailored, patient‐understandable information. CONCLUSION: Individuals at risk of RA are currently the subjects of research aimed at developing better predictive strategies and preventive approaches. Their perceptions and needs should be addressed to inform the future development of interventions combined with education. John Wiley and Sons Inc. 2020-02-27 2020-03 /pmc/articles/PMC7064954/ /pubmed/30710453 http://dx.doi.org/10.1002/acr.23841 Text en © 2019 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Rheumatoid Arthritis
Mosor, Erika
Stoffer‐Marx, Michaela
Steiner, Günter
Raza, Karim
Stack, Rebecca J.
Simons, Gwenda
Falahee, Marie
Skingle, Diana
Dobrin, Mircia
Schett, Georg
Englbrecht, Matthias
Smolen, Josef S.
Kjeken, Ingvild
Hueber, Axel J.
Stamm, Tanja A.
I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis
title I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis
title_full I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis
title_fullStr I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis
title_full_unstemmed I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis
title_short I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis
title_sort i would never take preventive medication! perspectives and information needs of people who underwent predictive tests for rheumatoid arthritis
topic Rheumatoid Arthritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064954/
https://www.ncbi.nlm.nih.gov/pubmed/30710453
http://dx.doi.org/10.1002/acr.23841
work_keys_str_mv AT mosorerika iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT stoffermarxmichaela iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT steinergunter iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT razakarim iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT stackrebeccaj iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT simonsgwenda iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT falaheemarie iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT skinglediana iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT dobrinmircia iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT schettgeorg iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT englbrechtmatthias iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT smolenjosefs iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT kjekeningvild iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT hueberaxelj iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis
AT stammtanjaa iwouldnevertakepreventivemedicationperspectivesandinformationneedsofpeoplewhounderwentpredictivetestsforrheumatoidarthritis